Heparin-Induced Thrombocytopenia Registry

National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients

NCT07268898 ·Status: NOT_YET_RECRUITING

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

NCT02273960 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)

NCT00946400 ·Status: UNKNOWN

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

NCT00759083 ·Status: WITHDRAWN ·Phase: PHASE4

Longitudinal Observational Study on Immune Thrombocytopenia

NCT07068425 ·Status: NOT_YET_RECRUITING

to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection

NCT03664518 ·Status: COMPLETED ·Phase: PHASE2

Explore the Relationship Between Platelet Count and Bleeding Score in ITP

NCT06273956 ·Status: RECRUITING

ITP Registry and Accompanying Biospecimen Collection

NCT05152238 ·Status: RECRUITING

Heparin-Induced Thrombocytopenia Score Card Study

NCT00489437 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

NCT02614846 ·Status: UNKNOWN ·Phase: PHASE1

Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)

NCT00603824 ·Status: WITHDRAWN ·Phase: PHASE4

Aplastic Anemia Epidemiology: Incidence and Case-control

NCT00005682 ·Status: COMPLETED

The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP

NCT03377439 ·Status: UNKNOWN

This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)

NCT02859909 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)

NCT04089267 ·Status: COMPLETED ·Phase: PHASE4

Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke

NCT07070193 ·Status: NOT_YET_RECRUITING

Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)

NCT06665308 ·Status: COMPLETED

Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

NCT00861692 ·Status: COMPLETED ·Phase: PHASE2

Bleeding In Thrombocytopenia Explained

NCT03505086 ·Status: RECRUITING

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

NCT05046327 ·Status: WITHDRAWN ·Phase: PHASE3

Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

NCT00454857 ·Status: COMPLETED

A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

NCT01440361 ·Status: WITHDRAWN ·Phase: PHASE2

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

NCT06291415 ·Status: WITHDRAWN ·Phase: PHASE1

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

NCT00673439 ·Status: TERMINATED ·Phase: PHASE2

A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

NCT07334093 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2